Abstract
The enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) catalyzes the interconversion between inactive 11-ketoglucocorticoids and their active 11β-hydroxy derivatives, such as cortisol and corticosterone. We have investigated the expression of 11β-HSD1 in freshly isolated human peripheral mononuclear leukocytes (MNL). The presence of 11β-HSD1 mRNA was demonstrated in total RNA by RT-PCR using specific primers designed on the 4th and 5th exons of the human 11β-HSD1 gene. Fragments of the expected size were consistently detected on agarose gels, and sequencing showed complete identity with the corresponding sequence deposited in GenBank. The occurrence of 11β-HSD1 protein was established by Western immunoblot analysis with a specific polyclonal antibody. Enzyme oxo-reductase activity was investigated by incubating 12 samples of MNL isolated from from 8 subjects with [3 H]cortisone and formation of cortisol was established only in 4 subjects (yield range: 0.15–1.3%) after acetylation and TLC, blank subtraction and correction for losses. 18β-Glycyrrhetinic acid, an inhibitor of 11 β-HSD1, reduced cortisol production below detection limit. Dehydrogenase activity could not be demonstrated. It is suggested that, although enzyme activity of 11β-HSD1 in circulating MNL is low, it is apparently ready for enhancement after MNL migration to sites of inflammation.
Key words
11β-hydroxysteroid dehydrogenase type 1 - human mononuclear leukocytes - inflammation - oxidative stress - receptors - glucocorticoids
References
-
1
Albiston AL, Obeyesekere VR, Smith RE. et al .
Cloning and tissue distribution of the human 11 beta- hydroxysteroid dehydrogenase type 2 enzyme.
Mol Cell Endocrinol.
1994;
105
R11-R17
-
2
Armanini D, Strasser T, Weber PC.
Characterization of aldosterone binding sites in circulating human mononuclear leucocytes.
Am J Physiol.
1985;
248
E388-E390
-
3
Caló LA, Zaghetto F, Pagnin E. et al .
Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes.
J Clin Endocrinol Metab.
2004;
89
1973-1976
-
4
Christ M, Meyer C, Sippel K. et al .
Rapid aldosterone signaling in vascular smooth muscle cells: involvement of phospholipase C, diacylglycerol and protein kinase Cα.
Biochem Biophys Res Comm.
1995;
213
123-129
-
5
Dandona P, Aljada A, Ghanim H. et al .
Acute suppressive effect of hydrocortisone on p47phox subunit of nicotinamide adenine dinucleotide phosphate oxidase.
Metabolism.
2001;
50
548-552
-
6
Draper N, Stewart PM.
11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action.
J Endocrinol.
2005;
186
251-271
-
7
Freeman L, Hewison M, Hughes SV. et al .
Expression of 11beta-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells.
Blood.
2005;
106
2042-2049
-
8
Johnstone JF, Bocking AD, Unlugedik E. et al .
The effects of chorioamnionitis and betamethasone on 11beta hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor in preterm human placenta.
J Soc Gynecol Investig.
2005;
12
238-245
-
9
Kasuya Y, Ishimaru H, Shibasaki H. et al .
Stable isotope methodology for kinetic studies of interconversion of cortisol and cortisone in a human subject.
Steroids.
1998;
63
122-129
-
10
Lio D, Candore G, Crivello A. et al .
Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease.
J Med Genet.
2004;
41
790-794
-
11
Murphy VE, Clifton VL.
Alterations in human placental 11beta-hydroxysteroid dehydrogenase type 1 and 2 with gestational age and labour.
Placenta.
2003;
24
739-744
-
12
Mziaut H, Korza G, Hand AR. et al .
Targeting proteins to the lumen of endoplasmic reticulum using N-terminal domains of 11β-hydroxysteroid dehydrogenase and the 50-kDa esterase.
J Biol Chem.
1999;
274
14122-14129
-
13
Odermatt A, Atanasov AG, Balazs Z. et al .
Why is 11 β-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen? Physiological relevance of the membrane topology of 11 β-HSD1.
Mol Cell Endocrinol.
2006;
248
15-23
-
14
Preisler MT, Weber PSD, Tempelman RJ. et al .
Glucocorticoid receptor expression profiles in mononuclear leukocytes of periparturient holstein cows.
J Dairy Sci.
2000;
83
38-47
-
15
Refojo D, Liberman AC, Holsboer F. et al .
Transcription factor-mediated molecular mechanisms involved in the functional cross-talk between cytokines and glucocorticoids.
Immunol Cell Biol.
2001;
79
385-394
-
16
Rook GA.
Glucocorticoids and immune function.
Baillieres Best Pract Res Clin Endocrinol Metab.
1999;
13
567-581
-
17
Schweizer RA, Zurcher M, Balazs Z. et al .
Rapid hepatic metabolism of 7-ketocholesterol by 11β-hydroxysteroid dehydrogenase Type 1: species-specific differences between the rat, human and hamster enzyme.
J Biol Chem.
2004;
279
18415-18424
-
18
Seckl JR.
11β-hydroxysteroid dehydrogenases: changing glucocorticoid action.
Curr Opin Pharmacol.
2004;
4
597-602
-
19
Thieringer R, Le Grand CB, Carbin L. et al .
11 Beta-hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages.
J Immunol.
2001;
167
30-35
-
20
Thieringer R, Le Grand CB, Mundt SS. et al .
11β-hydroxysteroid dehydrogenase type 1 is expressed in human monocytes upon differentiation to macrophages as well as in THP-1 cells, a human macrophage-like cell line.
, 82nd Annual Meeting of the Endocrinology Society, Toronto, ON, Canada, 2000: 21–24
-
21
Tomlinson JW, Moore J, Cooper MS. et al .
Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines.
Endocrinology.
2001;
142
1982-1989
-
22
Wehling M, Armanini D, Strasser T. et al .
Effect of aldosterone on sodium and potassium concentration in human mononuclear leucocytes.
Am J Physiol.
1987;
252
E505-E508
-
23
Zhang TY, Ding X, Daynes RA.
The expression of 11 beta-hydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities.
J Immunol.
2005;
174
879-889
1 These authors contributed equally.
Correspondence
D. ArmaniniMD
Department of Medical and Surgical Sciences-Endocrinology
University of Padua
Via Ospedale 105
35128 Padua
Italy
Phone: +39/049/821 30 23
Fax: +39/049/65 73 91
Email: decio.armanini@unipd.it